What will the world of AI-powered drug discovery look like?
Authored by Thomas Swalla, CEO of Dotmatics and published by Fox News
- 3 things to understand how AI might help develop new, cost-effective drug treatments -
is an industry insider take on the role of AI in life sciences.
It examines how AI is poised to reshape drug development, potentially saving billions of dollars and bringing life-changing therapies to patients faster. Insights from Thomas Swalla, CEO of Dotmatics include:
Why the industry is (finally) set up to succeed
What barriers remain — and why they’re getting bigger
How small wins add up to transformative change
Read the full Fox News article here
Learn More About Dotmatics
Meet with a product expert to see how Dotmatics uses AI technologies to drive down the cost of drug discovery.